NeuPath Health Inc. (TSXV:NPTH)

NeuPath Health Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.54	4.47	2.92	3.18	1.52	5.9
Cash & Short-Term Investments	3.54	4.47	2.92	3.18	1.52	5.9
Cash Growth	-20.14%	52.99%	-7.99%	109.43%	-74.30%	-45.59%
Accounts Receivable	9.36	8.67	7.43	6.66	6.98	6.61
Other Receivables	-	-	0.24	0.21	1.91	1.86
Receivables	9.36	8.67	7.67	6.87	8.89	8.47
Other Current Assets	0.71	0.75	0.53	0.61	0.67	0.99
Total Current Assets	13.61	13.89	11.12	10.66	11.08	15.37
Property, Plant & Equipment	9.51	9.46	8.21	9.07	11.54	11.6
Goodwill	20.75	20.75	20.75	20.72	20.72	20.72
Other Intangible Assets	0.54	0.59	0.63	0.71	1	3.05
Long-Term Deferred Tax Assets	0.03	0.03	0.07	0.01	-	-
Other Long-Term Assets	0.4	0.38	0.52	0.62	0.74	0.61
Total Assets	44.83	45.09	41.3	41.78	45.09	51.34

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.36	10.87	8.45	7.54	8.8	7.53
Accrued Expenses	-	-	-	-	-	0.75
Short-Term Debt	-	-	3.67	-	-	-
Current Portion of Long-Term Debt	0.65	0.65	2.08	0.2	3.09	3.44
Current Portion of Leases	1.21	1.11	1.1	1.13	1.55	1.37
Current Income Taxes Payable	0.05	0.13	0.08	0.29	0.43	0.26
Other Current Liabilities	-	-	-	-	-	0.35
Total Current Liabilities	12.27	12.77	15.38	9.15	13.87	13.71
Long-Term Debt	5.36	5.53	-	5.44	3.67	4.96
Long-Term Leases	5.87	5.85	4.49	5.35	5.86	6.63
Long-Term Deferred Tax Liabilities	-	-	-	-	0.03	0.07
Other Long-Term Liabilities	-	-	-	-	-	0.15
Total Liabilities	23.5	24.14	19.87	19.94	23.43	25.51

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	43.46	43.56	44.05	44.13	39.92	36.83
Additional Paid-In Capital	4.62	4.53	3.26	3.1	2.89	1.62
Retained Earnings	-27.15	-27.47	-26.75	-26.02	-25.92	-21.77
Comprehensive Income & Other	-	-	0.85	0.85	4.88	9.16
Total Common Equity	20.93	20.62	21.4	22.05	21.78	25.83
Minority Interest	0.4	0.33	0.03	-0.22	-0.13	-
Shareholders' Equity	21.32	20.95	21.43	21.84	21.65	25.83
Total Liabilities & Equity	44.83	45.09	41.3	41.78	45.09	51.34

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	13.09	13.14	11.35	12.12	14.17	16.4
Net Cash (Debt)	-9.56	-8.67	-8.43	-8.94	-12.65	-10.5
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.16	-0.15	-0.15	-0.16	-0.26	-0.23
Filing Date Shares Outstanding	56.18	56.26	56.15	56.29	54.6	46.56
Total Common Shares Outstanding	56.18	56.31	56.39	56.29	50.29	46.56
Working Capital	1.34	1.13	-4.26	1.51	-2.79	1.66
Book Value Per Share	0.37	0.37	0.38	0.39	0.43	0.55
Tangible Book Value	-0.36	-0.72	0.02	0.63	0.06	2.06
Tangible Book Value Per Share	-0.01	-0.01	0.00	0.01	0.00	0.04
Land	-	-	-	-	0.33	0.33
Buildings	-	-	-	-	0.87	0.87
Machinery	-	3.15	2.73	2.46	2.27	1.79
Leasehold Improvements	-	5.64	5.35	4.68	4.84	4.08

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error